Ces Urol 2005, 9(3):20-25 | DOI: 10.48095/cccu2005017

Case history duration and symptomatology in prognosis of renal carcinoma

I. Kawaciuk, L. Hyršl, P. Dušek, L. Jarolím, M. Schmidt, V. Kaliská, M. Chocholatý, M. Urbanová
Urologická klinika 2. LF UK a FN Motol, Praha

High erythrocytes sedimentation rate (p = 0,04), anemia (p = 0,01) and especially systemic toxic tumor symptoms (p < 0,01) were markers of significantly worse prognosis. Prognosis of patients with pain (p = 0,80) and fever (p = 0,83) was not different from survival of patients with hematuria. Prognosis with palpable mass (p = 0,13), classic tumor trias (p = 0,09) and hepatopathy (p = 0,38) was only insignificantly worse. On the contrary, patients with erytrocytosis (p = 0,82) and with hypertension in connection with tumor (p = 0,12) had only insignificant better survival. Survival was significantly poor, especially in patients with metastatic tumor manifestation (p < 0,01).

Keywords: renal cell carcinoma, prognosis, natural history, symptomatology

Published: June 1, 2005 

Open full article

References

  1. Kantor AF. Current concepts in the epidemiology and etiology of primary renal cell carcinoma. J Urol 1977;117:415-417. Go to original source... Go to PubMed...
  2. Borisova-Chromenko VM, Nejmark AI, Loginova LA. Diagnostika i ischody lečenija raka počki. Urol Nefrol (Mosk) 1977; 6: 60-63.
  3. Barsel VA, CHaimčajev JS. Matematičeskij analiz využivajemosti bolnych adenokarcinomoj počki. Urol Nefrol (Mosk.) 1975; 3: 44-48.
  4. Thompson IM, Shannon H, Ross G et al. An analysis of factors affecting survival in 150 patients with renal carcinoma. J Urol 1975; 114: 694-696. Go to original source... Go to PubMed...
  5. Lieber MM, Tomera FM, Taylor WF et al. Renal adenocarcinoma in young adults: survival and variables affecting prognosis. J Urol 1981; 125: 164-168. Go to original source... Go to PubMed...
  6. Flocks RH, Kadesky MC. Malignant neoplasma of the kidney: an analysis of patients followed five years or more. J Urol 1958; 79: 196-201. Go to original source... Go to PubMed...
  7. Holland JM. Cancer of the kidney - natural history and standing. Cancer 1973; 32: 1030-1042. Go to original source... Go to PubMed...
  8. Warren M, Kelalis P, Utz D. The changing concept of hypernephroma. J Urol 1970; 104: 376-379. Go to original source... Go to PubMed...
  9. Skinner DG, Colvin RB, Vermillion CD et al. Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 1971; 28: 1165-1177. Go to original source... Go to PubMed...
  10. Lokich JJ, Harrison JJ. Renal cell carcinoma: natural history and chemotherapeutic experience. J Urol 1975; 114: 371-374. Go to original source... Go to PubMed...
  11. Rűedi P, Mayor G, Sulmoni A. Klinische und therapeutische Erfahrungen an der Urologischen Universitätsklinik Zürich bei 156 Hypernephromfällen. Zschr Urol Bd 1975; 68: 493-498.
  12. Ekelund E, Jonsson K. How is renal carcinoma detected? Intern Urol and Nephrol 1977; 9: 3-10. Go to original source... Go to PubMed...
  13. Hemmingsen L, Skaarup P. Urinary excretion of ten plasma proteins in patients with renal carcinoma. Scand J Urol Nephrol 1977; 11: 41-46. Go to original source... Go to PubMed...
  14. Waters WB, Riches JP. Aggressive surgical approach to renal cell carcinoma. Review of 130 cases. J Urol 1979; 122 306-309. Go to original source... Go to PubMed...
  15. Boxer RJ, Waisman J, Lieber MM et al. Renal cell carcinoma: computer analysis of 96 patients treated by nephrectomy. J Urol 1979; 122 598-601. Go to original source... Go to PubMed...
  16. Bono AV, Lovisolo JA. Renal cell carcinoma - diagnosis and treatment: state of the art. Eur Urol 1997; 31, Suppl: 47-55. Go to original source... Go to PubMed...
  17. De Kernion JB, Berry D. The diagnosis and treatment of renal cell carcinoma. Cancer 1980; 45: 1947-1956. Go to original source... Go to PubMed...
  18. Petkovič S. Classification (staging) of renal parenchymal tumors. Intern Urol and Nephrol 1978; 10: 167-184. Go to original source... Go to PubMed...
  19. Trapeznikova MF. Sovremennyje aspekty svetlokletočnovo raka počki. Urol Nefrol (Mosk) 1977; 5: 56-61.
  20. McDougal WS, Garnick MB. Clinical signs and symptoms of renal cell carcinoma. In: Vogelzang NJ, Scardino PT, Shipley WU et al (eds). Comprehensive Textbook of Genitourinary Oncology. Philadelphia: Lippincott Williams & Wilkins 2000: 1011-1015.
  21. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol 2001; 166: 1611-1623. Go to original source... Go to PubMed...
  22. Murphy GP, Schirmer HKA. The diagnosis and treatment of hypernephroma. Geriatrics 1963; 18: 354-360.
  23. Böttiger LE. Prognosis in renal carcinoma. Cancer 1970; 26: 780-787. Go to original source... Go to PubMed...
  24. Rawlins MD, Luff RH, Cranston WI. Pyrexia in renal carcinoma. Lancet 1970; 27: 1371-1373. Go to original source...
  25. Chisholm GD, Roy RR. The systemic effects of malignant renal tumors. Br J Urol 1971; 43: 687-691. Go to original source... Go to PubMed...
  26. Báňa J, Dušek J, Burda M. Pozorování Grawitzova nádoru sdruženého s arteriovenózní píštělí ledviny. Rozhl Chir 1966; 45: 670-673.
  27. Cummings KB, Robertson RP. Prostaglandin: increased production by renal cell carcinoma. J Urol 1977; 118: 720-723. Go to original source... Go to PubMed...
  28. Surfin G, Chason S, Golio A et al. Paraneoplastic and serologic or renal adenocarcinoma. Semin Urol 1989; 7: 158-171.
  29. Michal M, Hes O, Mukenšnabl P (eds). Nádory ledvin dospělého věku. Plzeň: Euroverlag 2000.
  30. Hollifield JW, Page DL, Smith C et al. Renin-secreting clear cell carcinoma of the kidney. Arch Intern Med 1975; 135: 859-862. Go to original source... Go to PubMed...
  31. Lebel M, Talbot J, Grose J et al. Adenocarcinoma of the kidney and hypertension: report of 2 cases with special emphasis on renin. J Urol 1977; 118: 923-927. Go to original source... Go to PubMed...
  32. Altaffer LF, Chenault OW. Paraneoplastic endocrinopathies associated with renal tumors. J Urol 1979; 122: 573-577. Go to original source... Go to PubMed...
  33. Sufrin G, Mirand EA, Moore RH et al. Hormones in renal cancer. J Urol 1977; 117: 433-438. Go to original source... Go to PubMed...
  34. Omland G. Polycythemia in renal carcinoma. Acta Med Scand 1959; 164: 451-454. Go to original source... Go to PubMed...
  35. Gross AJ, Wolff M, Fandrey J et al. Prevalence of paraneoplastic erythropoietin production by renal cell carcinoma. Clin Invest 1994; 72: 337-340. Go to original source... Go to PubMed...
  36. Bennington JL. Cancer of the kidney - etiology, epidemiology and pathology. Cancer 1973; 32: 1017-1029. Go to original source... Go to PubMed...
  37. Goldberg MF, Tahjian AH, Order SE et al. Renal adenocarcinoma containing a parathyroid hormone-like substance and associated with marked hypercalcemia. Am J Med 1964; 36: 805-814. Go to original source... Go to PubMed...
  38. Body J. Bisphosphonates. Eur J Cancer 1998; 34: 263-269. Go to original source... Go to PubMed...
  39. Gold PJ, Fefer A, Thompson JA. Paraneoplastic manifestations of renal cell carcinoma. Semin Urol Oncol 1996; 14: 216-222.
  40. Stauffer MH. Nephrogenic hepatosplenomegaly. Gastroenterology 1961; 40: 694-699.
  41. Walsh PN, Kissane JM. Nonmetastatic hypernephroma with reversible hepatic dysfunction. Arch Int Med 1968; 122: 214-216. Go to original source...
  42. Rosenblum SL. Paraneoplastic syndromes associated with renal cell carcinoma. J S C Med Assoc 1987; 83: 375-378.
  43. Vermillion CD, Morlock CG, Bartholomew LG et al. Nephrogenic hepatic dysfunction: secondary to tumefactive xanthogranulomatous pyelonephritis. Ann Surg 1970; 171: 130-133. Go to original source... Go to PubMed...
  44. Blay JY, Rossi JF, Eijdenes J et al. Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal cell carcinoma. Int J Cancer 1997; 72: 424-430. Go to original source... Go to PubMed...
  45. Kaufman JJ, Mims MM. Tumor of the kidney. In: Ravitch EE et al (eds). Current problems in surgery. Chicago: Year Book Medical Publishers 1966: 1-44. Go to original source...
  46. Hannisdal E, Bostad L, Grottum KA et al. Erythrocyte sedimentation rate as a prognostic factor in renal cell carcinoma. Eur J Surg Oncol 1989; 15: 333-336.
  47. Inoue T, Hashimura T, Iwamura H et al. Multivariate analysis of prognostic determinants after surgery for renal cell carcinoma at Himeji National Hospital. Hinyokika Kiyo 2000; 46: 229-234.

Return to the content



Web časopisu Česká urologie je určen pouze pro lékaře a odborníky
z oblasti medicíny nebo farmacie.



Beru na vědomí, že informace zveřejněné na těchto stránkách
nejsou určeny pro laickou veřejnost.


Odejít Vstoupit